Bibliographic information
GuidelineConsolidated guidelines on HIV prevention, testing, treatment, service delivery and monitoring: recommendations for a public health approach
Year of Publication2021
Issuing InstitutionWHO
Recommendation
New
dolutegravir (DTG) is recommended as the preferred third drug for HIV post-exposure prophylaxis for children for whom an approved DTG dosing is available
Recommended in favor
Strong
Certainty of evidence
Low